Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

8U1G

Prefusion-stabilized SARS-CoV-2 S2 subunit

Summary for 8U1G
Entry DOI10.2210/pdb8u1g/pdb
DescriptorSpike protein S2, 2-acetamido-2-deoxy-beta-D-glucopyranose (2 entities in total)
Functional Keywordssars-cov-2 spike, s2-only antigen, prefusion-stabilized stem, viral protein
Biological sourceSevere acute respiratory syndrome coronavirus 2 (2019-nCoV, SARS-CoV-2, COVID-19 virus)
Total number of polymer chains2
Total formula weight116841.30
Authors
Hsieh, C.-L.,McLellan, J.S. (deposition date: 2023-08-31, release date: 2024-01-24, Last modification date: 2024-11-20)
Primary citationHsieh, C.L.,Leist, S.R.,Miller, E.H.,Zhou, L.,Powers, J.M.,Tse, A.L.,Wang, A.,West, A.,Zweigart, M.R.,Schisler, J.C.,Jangra, R.K.,Chandran, K.,Baric, R.S.,McLellan, J.S.
Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge.
Nat Commun, 15:1553-1553, 2024
Cited by
PubMed Abstract: Ever-evolving SARS-CoV-2 variants of concern (VOCs) have diminished the effectiveness of therapeutic antibodies and vaccines. Developing a coronavirus vaccine that offers a greater breadth of protection against current and future VOCs would eliminate the need to reformulate COVID-19 vaccines. Here, we rationally engineer the sequence-conserved S2 subunit of the SARS-CoV-2 spike protein and characterize the resulting S2-only antigens. Structural studies demonstrate that the introduction of interprotomer disulfide bonds can lock S2 in prefusion trimers, although the apex samples a continuum of conformations between open and closed states. Immunization with prefusion-stabilized S2 constructs elicits broadly neutralizing responses against several sarbecoviruses and protects female BALB/c mice from mouse-adapted SARS-CoV-2 lethal challenge and partially protects female BALB/c mice from mouse-adapted SARS-CoV lethal challenge. These engineering and immunogenicity results should inform the development of next-generation pan-coronavirus therapeutics and vaccines.
PubMed: 38378768
DOI: 10.1038/s41467-024-45404-x
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (3.2 Å)
Structure validation

227561

PDB entries from 2024-11-20

PDB statisticsPDBj update infoContact PDBjnumon